Clinical Implications of Sarcopenia in Patients Undergoing Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertention
Pulmonary endarterectomy (PEA) is a curative surgical option for patients with chronic thromboembolic pulmonary hypertension (CTEPH), a disease resulting from chronic pulmonary thromboembolism. The role of sarcopenia (i.e. low skeletal muscle mass) has been shown to be associated with adverse outcomes in surgical populations, but its significance with PEA remains unknown. We sought to evaluate the association of sarcopenia with measures of CTEPH severity and post-operative hospital outcomes.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: I. Balki, M.D. Perrot, F. Zaeimi, J.T. Granton, J. Thenganatt, M. McInnis, L. Donahoe, D. Rozenberg Tags: (57) Source Type: research
More News: Cardiology | Heart | Heart Transplant | Hospitals | Hypertension | Lung Transplant | Pulmonary Hypertension | Pulmonary Thromboembolism | Thrombosis | Transplant Surgery | Transplants